CHAPTER III . SECTION 1

AI Act Article 6: Classification rules for high-risk AI systems

1. Irrespective of whether an AI system is placed on the market or put into service independently of the products referred to in points (a) and (b), that AI system shall be considered to be high-risk where both of the following conditions are fulfilled:

(a) the AI system is intended to be used as a safety component of a product, or the AI system is itself a product, covered by the Union harmonisation legislation listed in Annex I;

(b) the product whose safety component pursuant to point (a) is the AI system, or the AI system itself as a product, is required to undergo a third-party conformity assessment, with a view to the placing on the market or the putting into service of that product pursuant to the Union harmonisation legislation listed in Annex I.

2. In addition to the high-risk AI systems referred to in paragraph 1, AI systems referred to in Annex III shall be considered to be high-risk.

3. By derogation from paragraph 2, an AI system referred to in Annex III shall not be considered to be high-risk where it does not pose a significant risk of harm to the health, safety or fundamental rights of natural persons, including by not materially influencing the outcome of decision making.

The first subparagraph shall apply where any of the following conditions is fulfilled:

(a) the AI system is intended to perform a narrow procedural task;

(b) the AI system is intended to improve the result of a previously completed human activity;

(c) the AI system is intended to detect decision-making patterns or deviations from prior decision-making patterns and is not meant to replace or influence the previously completed human assessment, without proper human review; or

(d) the AI system is intended to perform a preparatory task to an assessment relevant for the purposes of the use cases listed in Annex III.

Notwithstanding the first subparagraph, an AI system referred to in Annex III shall always be considered to be high-risk where the AI system performs profiling of natural persons.

4. A provider who considers that an AI system referred to in Annex III is not high-risk shall document its assessment before that system is placed on the market or put into service. Such provider shall be subject to the registration obligation set out in Article 49(2). Upon request of national competent authorities, the provider shall provide the documentation of the assessment.

5. The Commission shall, after consulting the European Artificial Intelligence Board (the ‘Board’), and no later than 2 February 2026, provide guidelines specifying the practical implementation of this Article in line with Article 96 together with a comprehensive list of practical examples of use cases of AI systems that are high-risk and not high-risk.

6. The Commission is empowered to adopt delegated acts in accordance with Article 97 in order to amend paragraph 3, second subparagraph, of this Article by adding new conditions to those laid down therein, or by modifying them, where there is concrete and reliable evidence of the existence of AI systems that fall under the scope of Annex III, but do not pose a significant risk of harm to the health, safety or fundamental rights of natural persons.

7. The Commission shall adopt delegated acts in accordance with Article 97 in order to amend paragraph 3, second subparagraph, of this Article by deleting any of the conditions laid down therein, where there is concrete and reliable evidence that this is necessary to maintain the level of protection of health, safety and fundamental rights provided for by this Regulation.

8. Any amendment to the conditions laid down in paragraph 3, second subparagraph, adopted in accordance with paragraphs 6 and 7 of this Article shall not decrease the overall level of protection of health, safety and fundamental rights provided for by this Regulation and shall ensure consistency with the delegated acts adopted pursuant to Article 7(1), and take account of market and technological developments.

What this article means in practice

Written by Engage Compliance. The text above is the article itself, reproduced from its official source and unchanged. Everything in this section is ours, and last read against the current text on 2026-09-07.

Article 6 is the question behind the Article 22 appointment: is your system high-risk. There are two routes in. Either it is a safety component of, or is itself, a product covered by the Annex I legislation that needs third-party conformity assessment, or it is listed in Annex III. Annex III carries a derogation with four conditions, and one thing overrides all of them.

Who it binds

  • Providers of AI systems, who have to classify their own system before placing it on the market. Article 6(4) requires a provider claiming an Annex III system is not high-risk to document that assessment BEFORE the system is placed on the market or put into service.
  • It reaches a system whether or not it is placed on the market independently of the product it sits in (Article 6(1)), so an AI component inside somebody else's regulated product is assessed on its own terms.
  • It does not classify by sector or by company size. Both routes turn on what the system does and what legislation covers the product.

What it makes somebody do

  • You, the provider. Classify against Article 6(1): is the system a safety component of, or itself, a product covered by Annex I Union harmonisation legislation, AND does that product require third-party conformity assessment. Both conditions have to be met.
  • You, the provider. Classify against Article 6(2): is the system listed in Annex III. If it is, it is high-risk unless the Article 6(3) derogation applies.
  • You, the provider. If you rely on the Article 6(3) derogation, document the assessment before the system is placed on the market or put into service (Article 6(4)).
  • You, the provider. Register under Article 49(2) where you have claimed the derogation (Article 6(4)). Claiming a system is not high-risk therefore creates a registration obligation rather than removing every obligation.
  • You, the provider. Provide the documentation of that assessment to national competent authorities on request (Article 6(4)).

What it does not say

  • The Article 6(3) derogation is not a general low-risk exemption. It applies only where the system does not pose a significant risk of harm AND one of the four listed conditions holds: a narrow procedural task, improving a previously completed human activity, detecting decision-making patterns without replacing human assessment, or a preparatory task.
  • Profiling ends the argument. Article 6(3) says notwithstanding the derogation, an Annex III system that performs profiling of natural persons is ALWAYS high-risk. No condition rescues it.
  • Claiming the derogation is not free. Article 6(4) turns it into a documentation duty and an Article 49(2) registration duty, so the choice is between two sets of obligations rather than between obligations and none.
  • Article 6 is not static. Article 6(6) and 6(7) let the Commission add to, modify or delete the derogation conditions by delegated act, so a classification made today is a classification under today's text.
  • It does not tell you what to DO about a high-risk system. The requirements are in Section 2 and the provider obligations in Article 16; Article 6 only decides whether they apply.

How it sits beside the other mandates

  • Article 6 is what makes Article 22 engage. A third-country provider only needs an authorised representative under Article 22 if the system is high-risk, so this article is upstream of the appointment.
  • Article 49 is where the registration duties sit, both for high-risk systems under Article 49(1) and for a derogation claim under Article 49(2), and Article 22(3)(e) puts part of that on the representative.
  • A company whose system is high-risk under Article 6 and which is established outside the EU commonly needs a GDPR Article 27 representative as well, because the systems in Annex III overwhelmingly process personal data.

Source text: EUR-Lex, Official Journal HTML (CELEX 32024R1689). The parser was validated against the anchor articles verified in REP-08.